Clinical Trial Update: Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Update on a phase 1/2 trial evaluating mogamulizumab in combination with nivolumab for locally advanced or metastatic solid tumors; results were posted after st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Solid Tumor

Drugs mentioned

• Mogamulizumab (mogamulizumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Kyowa Kirin, Inc. | Conditions: Solid Tumor, Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-06-04